Could a narcolepsy drug help ICU patients finally get real sleep?

NCT ID NCT07596342

First seen May 20, 2026 · Last updated May 25, 2026 · Updated 1 time

Summary

This study tests whether a medication called gamma-hydroxybutyrate (GHB) can improve deep, restorative sleep in intensive care patients. Sleep problems are very common in the ICU and can cause discomfort and health issues. The trial will involve 24 adults in the ICU and measure sleep quality using brain wave recordings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL CARE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Intensive Care Unit, Hospital Pitié Salpêtrière

    Paris, Île-de-France Region, 75013, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.